| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Processa Pharmaceuticals, Inc. (PCSA) has 11 insiders with recent SEC Form 4 filings, including 9 buys and 3 sells. PCSA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 288.0K | $705.6K | - | |
| Dir | 67.5K | $165.3K | - | |
| Dir | 38.7K | $94.9K | - | |
| Dir | 38.7K | $94.9K | - | |
| Dir | 38.7K | $94.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | Lin Patrick | Chief Business - Strategy Off | Buy | 2,000 | $1.59 | $3,189.00 | +0.5% | +72.5% | -65.1% | |
| Apr 7, 2022 | Lin Patrick | Chief Business - Strategy Off | Buy | 2,000 | $3.29 | $6,587.08 | +0.2% | -7.9% | -86.8% | |
| Jan 27, 2022 | Yorke Justin W56 | Director | Sell | 1,854 | $3.30 | $6,118.20 | -0.3% | -19.3% | -73.5% | |
| Dec 14, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 3,000 | $4.00 | $12,000.00 | +0.7% | -12.7% | -51.1% | |
| Dec 14, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 3,000 | $4.00 | $12,000.00 | +0.7% | -12.7% | -51.1% | |
| Dec 6, 2021 | Yorke Justin W56 | Director | Sell | 9,700 | $4.78 | $46,382.78 | -0.9% | -23.4% | -60.6% | |
| Dec 3, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 3,500 | $4.80 | $16,795.10 | +0.8% | -18.9% | -60.3% | |
| Aug 26, 2021 | Lin Patrick | Chief Business - Strategy Off | Buy | 4,000 | $6.02 | $24,088.00 | +1.0% | -5.5% | -50.4% | |
| Jun 23, 2021 | Young David | Chief Executive Officer | Buy | 10,000 | $7.67 | $76,716.00 | +3.0% | -4.1% | -61.8% | |
| Jun 22, 2021 | Floyd Robert Michael | Chief Operating Officer | Buy | 2,000 | $7.03 | $14,058.40 | +7.7% | +1.4% | -60.2% |